4th Quarter - Report
ZIMMER BIOMET, INC. for ZIMMER BIOMET, INC.
Firm
Client
Income
—
Expenses
$130,000
Expense method
A: Lobbying Disclosure Act definitions
What was lobbied
5 issue areas, each in the filer's own words, with who lobbied on it and where.
Taxation/Internal Revenue Code TAX
Y21 Omnibus Spending bills, with emphasis on various Medicare and Corporate Tax provisions; Tax Cuts and Jobs Act, Internal Revenue Code Sections 163j, 965; CFC look-through extension; tax extenders
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANDREW JAMES FRANKE | — |
Medicare/Medicaid MMM
Medicare and Corporate Tax provisions
| Lobbyist | Covered position, as disclosed |
|---|---|
| CHRISTOPHER A CERONE | — |
Budget/Appropriations BUD
CARES Act; Consolidated Appropriations Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| HEATHER FALEN ASHBY | — |
| ANDREW JAMES FRANKE | — |
Trade (domestic/foreign) TRD
implementation of Administration Executive Orders related to China sanctions
| Lobbyist | Covered position, as disclosed |
|---|---|
| CHRISTOPHER A CERONE | — |
Health Issues HCR
Year-end COVID Relief and FY21 Omnibus Spending bills; COVID vaccine allocation and funding
| Lobbyist | Covered position, as disclosed |
|---|---|
| CHRISTOPHER A CERONE | — |
| ANDREW JAMES FRANKE | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.